title: [Immune effects of three different programs for revaccination among adults of non- and hypo-responders to hepatitis B vaccine].
abstract: OBJECTIVE
  To investigate the immune effects of three different programs for revaccination among adults of non- and hypo-responders to recombinant Hepatitis B vaccine.
  
  
  METHODS
  Those who were once immunized with recombinant Hepatitis B vaccine more than one standard schedule (0, 1, and 6 months) in two years and negative for Hepatitis B markers were randomly given three-different projects for revaccination. 34 adults of A group were given GM-CSF 300 microg by subcutaneous injection for the first day, then 10 microg each time by intramuscular route for routine immune method. 33 adults of B group were given Hepatitis B vaccine 20 microg each time. 33 adults of C group were given Hepatitis B vaccine 10 microg each time. The blood samples were collected before the first injection and in 1, 2 and 8 months following the first injection to test Anti-HBs.
  
  
  RESULTS
  At T1, the anti-HBs positive conversion rate of group A, B and C was 26.47%, 48.48% and 18.18% respectively (chi-2 = 7.20, P = 0.027). At T8, the anti-HBs positive conversion rate of group A (64.71%) and group B (75.76%) were higher than group C (39.39%), and there was significant difference (chi-2 = 9.07, P = 0.011). At T1, the anti-HBs level of group B (417.00 +/- 69.36) was higher than that of group A (203.74 +/- 79.56). At T2, the anti-HBs level of group B (458.17 +/- 64.09) was higher than that of group C (257.86 +/- 76.60). At T8, the anti-HBs level of group A (501.48 +/- 70.00) and group B (532.73 +/- 68.82) were higher than those of group C (256.12 +/- 75.39) (t =4.27, P = 0.0173).
  
  
  CONCLUSIONS
  Schemes of augmentation doses of Hepatitis B vaccine and being combined with GM-CSF should be in effect for non- and hypo-responders to Hepatitis B vaccine.
authors.affiliation: Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China.
authors.forename: Chao-shuang
authors.initials: CS
authors.lastname: Lin
authors.forename: Xiang-yang
authors.initials: XY
authors.lastname: Wang
authors.forename: He-xiang
authors.initials: HX
authors.lastname: Chen
authors.forename: Wen-hui
authors.initials: WH
authors.lastname: Lee
authors.forename: Hong-tao
authors.initials: HT
authors.lastname: He
authors.forename: Zhi-liang
authors.initials: ZL
authors.lastname: Gao
mesh_terms: D000293:Adolescent; D000328:Adult; D000917:Antibody Formation; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000276:immunology; D006510:Hepatitis B Antibodies / Q000097:blood*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage* / Q000276:immunology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D055815:Young Adult
chemical_list: D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines; D016178:Granulocyte-Macrophage Colony-Stimulating Factor